ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HDVY Health Discovery Corporation (CE)

0.000001
0.00 (0.00%)
13 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Health Discovery Corporation (CE) USOTC:HDVY OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 00:00:00

Current Report Filing (8-k)

02/08/2013 8:04pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  July 29, 2013

 

 

Health Discovery Corporation

(Exact name of registrant as specified in charter)

 

 

Georgia 333-62216 74-3002154
(State of incorporation) (Commission File Number)

(IRS Employer

Identification No.)

 

 

620 County Road, Hansson, MA 02341

(Address of principal executive offices / Zip Code)

 

 

678-336-5300

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  o Written communications pursuant to Rule 425 under the Securities Act.
  o Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
  o Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
  o Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

 

 

 
 

  

ITEM 8.01 Other Information

 

 

On July 29, 2013, Health Discovery Corporation (the “Company”) entered into a settlement agreement with Stephen D. Barnhill, the former Chairman and Chief Executive Officer of the Company.  Under the terms of the Settlement Agreement, (i) the Company paid $50,000 to, or for the benefit of, Dr. Barnhill and (ii) Dr. Barnhill executed a general release in favor of the Company, subject to any indemnification rights that Dr. Barnhill may have under any agreement, law, or insurance policy maintained by the Company.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Not applicable
(b) Not applicable
(c) Not applicable
(d) Exhibits.
   
  None

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

  HEALTH DISCOVERY CORPORATION

 

 

 

 

   
Dated:  August 2, 2013 By: /s/ John A. Norris, J.D.,M.B.A.  
    Chief Executive Officer
     

 

1 Year Health Discovery (CE) Chart

1 Year Health Discovery (CE) Chart

1 Month Health Discovery (CE) Chart

1 Month Health Discovery (CE) Chart